Holen Sie sich die Stockscreener-App
10.29
5.11%
0.50
Finanzdaten der Transcode Therapeutics Inc-Aktie (RNAZ)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
33.11%
4.2211
|
3.1712 | 5.1139 | 3.289 | 4.059 |
| Operating Income/Loss |
33.11%
-4.2211
|
-3.1712 | -5.1139 | -3.289 | -4.059 |
| Nonoperating Income/Loss |
99.38%
-0.0554
|
-8.9142 | -0.0769 | -0.0378 | -0.0285 |
| Income/Loss From Continuing Operations Before Tax |
64.61%
-4.2765
|
-12.09 | -5.1908 | -3.3268 | -4.0875 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
64.61%
-4.2765
|
-12.09 | -5.1908 | -3.3268 | -4.0875 |
|
Net Income/Loss
|
64.61%
-4.2765
|
-12.09 | -5.1908 | -3.3268 | -4.0875 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
82.72%
0.8337
|
4.8233 | 7.0511 | 5.1424 | -1.5299 |
| Diluted Average Shares |
82.72%
0.8337
|
4.8233 | 7.0511 | 5.1424 | -1.5299 |
| Basic Earnings Per Share |
104.38%
-5.13
|
-2.51 | -0.74 | -0.65 | -95.15 |
| Diluted Earnings Per Share |
104.38%
-5.13
|
-2.51 | -0.74 | -0.65 | -95.15 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.95%
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):